GP-Act III Acquisition Corp. GPAT
Last close
11.01
2026-10-22
Market cap
—
52-week range
10.57 - 12.00
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS—
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| SG&A | $551.9K | $565.0K | $14.0K | — |
| Operating income | -$551.9K | -$565.0K | -$14.0K | — |
| Net income | $11.9M | $8.7M | -$14.0K | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash and equivalents | $112.7K | $483.6K | $1.2K | $1.8K |
| Total current assets | $188.1K | $675.4K | $3.3K | — |
| Total assets | $309.4M | $297.5M | $530.2K | — |
| Total current liabilities | $634.6K | $631.6K | $628.2K | — |
| Total liabilities | $14.7M | $14.7M | $628.2K | — |
| Retained earnings | -$14.5M | -$13.9M | -$122.9K | — |
| Total equity | -$14.5M | -$13.9M | -$97.9K | -$83.9K |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Operating cash flow | -$372.2K | -$584.7K | -$11.0K | — |
| Investing cash flow | — | -$287.5M | — | — |
| Financing cash flow | $1.3K | $288.6M | $10.4K | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-034846.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Net income | — | -$14.0K | $8.7M | $11.9M |
Recent filings and events
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Material agreement signed Item 1.01
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Shareholder vote Item 5.07
- Other event Item 8.01
- Shareholder vote Item 5.07
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Annual report filed Form 10-K
- Other event Item 8.01
- Other event Item 8.01
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 6770
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| DMII | Drugs Made In America Acquisition II Corp. | $649.1M | — | — |
| IACO | Idea Acquisition Corp. | $437.9M | — | — |
| KRAQ | KRAKacquisition Corp | $430.8M | — | — |
| TACO | Berto Acquisition Corp. | $393.2M | 36.1x | — |
| ALDF | Aldel Financial II Inc. | $328.0M | — | — |
| ATII | Archimedes Tech SPAC Partners II Co. | $290.3M | — | — |
| FGII | FG Imperii Acquisition Corp. | $290.3M | — | — |
| SOUL | Soulpower Acquisition Corp. | $269.3M | — | — |